Pillstats
Labeler · US market

Biocon Biologics Inc.

Biocon Biologics Inc. is a US drug labeler with US FDA registrations covering 12 drug concepts (12 currently active) across 26 packages. It is currently the only active US supplier of 8 drugs. The company files with FDA under 2 name variants, merged into this profile.

Also files as: Biocon Biologics Limited

ACTIVE — US
openFDA · updated weekly
Labeler codes82196 · 83257
Active drugs12
Registrations21 active / 25
Packages26
Sole supplier of8 drugs

Portfolio12 drugs · US

Every drug concept this labeler has US registrations for, by package count.

DrugTypeNDCsPackagesStatus
Insulin Glargine-Yfgn
injection, solution
rx46SUPPLYING
Adalimumab-Fkjp
kit
rx55SUPPLYING
Ustekinumab
injection, solution
rx33SUPPLYING
Insulin Aspart-Xjhz
injection, solution
rx22SUPPLYING
Denosumab-Kyqq
injection
rx22SUPPLYING
Bevacizumab-Nwgd
injection
rx22SUPPLYING
Pegfilgrastim-Jmdb
injection
rx11SUPPLYING
Water
injection, solution
rx11SUPPLYING
Trastuzumab-Dkst
injection, powder, lyophilized, for solution
rx21SUPPLYING
Ustekinumab
solution
rx11SUPPLYING
Insulin
powder
other11SUPPLYING
Trastuzumab-Dkst
kit
rx11SUPPLYING